An interventional study of PICO, Smith & Nephew in Negative Pressure Wound Therapy, Vacuum Therapy and Closed Incisions, sponsored by J.C. Goslings. Completed at 1 site in Netherlands. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2018-01-19.
Sponsored by J.C. Goslings · Not applicable, Interventional, and Prevention
Prophylactic use of Negative Pressure Wound Therapy (NPWT) on surgical wounds following lower extremity orthopedic trauma to prevent infectious complications.
5,056 studies on the registry are indexed under Wounds and Injuries; 861 are open to participants now.
This study's enrollment of 60 is above the median of 52 across 3,239 interventional studies indexed under Wounds and Injuries.
Browse Wounds and Injuries studies →This is the only study on the registry with J.C. Goslings as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Prophylactic negative pressure wound therapy
Device: PICO, Smith & Nephew
Direct application of negative pressure wound therapy following Foot and Ankle surgery
Number patients with postoperative wound infections (POWI) as classified bij the Centers for Disease Control and prevention (CDC)-criteria.
The number of POWI's within 30 days of surgery will be recorded. These will be classified in superficial and deep POWI's using the criteria as proposed by the CDC.
Time frame: 30 days
The American Orthopaedic Foot and Ankle Score (AOFAS) will be measured at six months
To asses functional outcome of the participants the AOFAS questionnaire will be used
Time frame: 6 months
EuroQol five dimensions questionnaire (EQ-5D)will be measured at six months
To asses the quality of life of the participants the EQ-5D questionnaire will be used
Time frame: 6 months
This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.